Login to Your Account



 
 

Not if, but when and how. That's the conclusion most biopharmaceutical executives have today when it comes to developing a global strategy — increasingly focused on Asia. China will likely be the second-largest pharmaceutical market by 2020, surpassing Japan. Surrounding countries, such as Taiwan and South Korea already have powerful biotechnology and biosimilars sub-sectors well established. To succeed in today's global economy an Asia strategy is not optional.

In response to a rapidly increasing demand for more news from this region, BioWorld Asia debuts to provide biopharma executives with a trusted, steady stream of content from this critical part of the world, providing information and data to help shape short- and long-term business decisions.

BioWorld Asia is a weekly publication that is modeled after BioWorld Today, which provides focused updates on business, financial, clinical, scientific and regulatory developments affecting the biopharma industry.

  • Read beyond the obvious, with timely, in-depth coverage of Asia's biopharma sector, with trademark BioWorld analysis and perspective on licensing deals, M&A and financings

  • Untangle the regulatory knots with articles that clarify the process in China and other key markets

  • Enhance partnering opportunities by getting to know the people and companies via BioWorld's signature BioPeople and NewCo News features

  • Recognize deal trends and various financing options available to fund R&D

  • Understand how the recent corruption scandals are affecting drug regulation in China and what that means for the biopharma industry

  • Comprehend the myriad regulatory paths for biosimilars

  • Assuage intellectual property concerns with articles that highlight this hot-button topic

  • Learn about joint regulatory schemes, such as one developing between Australia and New Zealand

  • Stay on top of clinical news with incremental updates on drugs in the pipeline from early to late-stage through regulatory reviews, approvals or denials

To place an order: Call 1-800-477-6307 or 1-770-810-3144 (Outside the U.S.) or email BioWorld.salessupport@thomsonreuters.com.